Propuesta de teoría de colas para optimizar el tiempo en las líneas de espera del área de cajas en la Caja Municipal de Ahorro y Crédito Sullana S.A. sede central Sullana, 2022

La investigación tuvo como propósito general elaborar una propuesta de servicio basado en la teoría de colas para reducir tiempo de espera al cliente en la Caja Municipal de Ahorro y Crédito Sullana S.A. El estudio fue bajo un enfoque cuantitativo con un diseño no experimental del tipo transversal-descriptivo. Se consideró una población de 460 clientes a los cuales se le aplicó un formato de reporte de tiempos bajo la técnica de observación directa y como instrumento un cuestionario de encuesta de 11 preguntas aplicado a 30 clientes para evaluar el tiempo de espera de la organización según sus usuarios. Se sintetizó la información mediante una hoja de cálculo en la herramienta Microsoft Excel en donde más del 50% de los usuarios consideran que la duración del tiempo de espera en la cola debe reducirse y más del 43% considera que la entidad debería contar con un mayor número de colaboradores atendiendo en cajas. Se utilizó la herramienta Winqsb para simular y así obtener el factor de utilización del sistema y la probabilidad de sistema ocioso para lo cual se evaluó con 5 servidores dando como resultado 88.77% y 15.21% respectivamente y aumentando a 6 el número de servidores 80.74% y 20% respectivamente concluyendo así que el aumento del número de servidores es una estrategia inadecuada. Por lo cual se plantea una propuesta de capacitación para mejorar la interacción cliente-usuario y reducir el tiempo de espera

Social Enterprises in the Canadian West

Western Canada has been the source of significant developments in the social enterprise sector over the past fifteen years. Among these developments one must include the formation of Enterprising Non-Profits in British Columbia, the Social Enterprise Fund in Alberta, and the Canadian CED Network in Manitoba. Underlying these more recent developments is a history of co-operative development and earned revenues by nonprofit organizations, reflecting a longstanding blend of entrepreneurship and community solidarity. This article highlights some of the more recent social enterprise developments in three Western provinces, profiling three independent cases that reflect the diversity of social enterprise activity in British Columbia, Alberta, and Manitoba, and providing the results of social enterprise sector surveys that took place in these same provinces in 2014.Depuis quinze ans, l’Ouest canadien a été la source de développements importants dans le secteur de l’entreprise sociale. Parmi ces développements, il faut inclure la formation : d’Enterprising Non-Profits en Colombie-Britannique; du Social Enterprise Fund en Alberta; et du Réseau canadien de DÉC au Manitoba. Sous-tendant ces progrès récents est une longue histoire de développements coopératifs et de revenus gagnés par des organismes sans but lucratif reflétant une combinaison d’entreprenariat et de solidarité communautaire. Cet article souligne certains des développements plus récents en entreprise sociale dans trois provinces de l’Ouest, recensant trois cas distincts qui reflètent la diversité des activités en entreprise sociale en Colombie-Britannique, en Alberta et au Manitoba, et présentant les résultats de sondages sur le secteur de l’entreprise sociale effectués dans ces trois provinces en 2014

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

BACKGROUND: Toll-like receptor (TLR)3 ligands serve as natural inducers of pro-inflammatory cytokines capable of promoting Type-1 adaptive immunity, and TLR3 is abundantly expressed by cells within the central nervous system (CNS). To improve the efficacy of vaccine strategies directed against CNS tumors, we evaluated whether administration of a TLR3 ligand, polyinosinic-polycytidylic (poly-IC) stabilized with poly-lysine and carboxymethylcellulose (poly-ICLC) would enhance the anti-CNS tumor effectiveness of tumor peptide-based vaccinations. METHODS: C57BL/6 mice bearing syngeneic CNS GL261 glioma or M05 melanoma received subcutaneous (s.c.) vaccinations with synthetic peptides encoding CTL epitopes- mEphA2 (671–679), hgp100 (25–33) and mTRP-2 (180–188) for GL261, or ovalbumin (OVA: 257–264) for M05. The mice also received intramuscular (i.m.) injections with poly-ICLC. RESULTS: The combination of subcutaneous (s.c.) peptide-based vaccination and i.m. poly-ICLC administration promoted systemic induction of antigen (Ag)-specific Type-1 CTLs expressing very late activation antigen (VLA)-4, which confers efficient CNS-tumor homing of vaccine-induced CTLs based on experiments with monoclonal antibody (mAb)-mediated blockade of VLA-4. In addition, the combination treatment allowed expression of IFN-γ by CNS tumor-infiltrating CTLs, and improved the survival of tumor bearing mice in the absence of detectable autoimmunity. CONCLUSION: These data suggest that poly-ICLC, which has been previously evaluated in clinical trials, can be effectively combined with tumor Ag-specific vaccine strategies, thereby providing a greater index of therapeutic efficacy

Notes on the Biology of an Adult Female Chimaera cubana Captured Off St. Croix, U.S. Virgin Islands

Within the western North Atlantic Ocean there are at least 4 genera and 5 species of chimaeroids occurring in deep waters generally associated with outer continental slopes or areas of high bathymetric relief (Didier 2002; Didier 2004). Two chimaeroids, Chimaera cubana and Hydrolagus alberti, are known to be indigenous to the Caribbean Sea in waters associated with the Greater and Lesser Antilles. While H. alberti occurs throughout the Gulf of Mexico and the Caribbean Sea, C. cubana is thought to be endemic to an area bounded by Cuba and Colombia (IUCN 2009). These two chimaeras are readily differentiated by the presence or absence of an anal fin and species–specific branching patterns of cranial lateral line canals (Didier 2004). Since the description of C. cubana by Howell–Rivero (1936), only 10 specimens have been reported in the primary literature with another 11 specimens located in museum collections (Bunkley–Williams and Williams 2004). The dearth of biological information on C. cubana led the International Union for the Conservation of Nature to recommend that “basic data be collected on all captures” (IUCN 2009)

Infall Signatures in a Prestellar Core embedded in the High-Mass 70 μ\mum Dark IRDC G331.372-00.116

Using Galactic Plane surveys, we have selected a massive (1200 M$_\odot$), cold (14 K) 3.6-70 $\mu$m dark IRDC G331.372-00.116. This IRDC has the potential to form high-mass stars and, given the absence of current star formation signatures, it seems to represent the earliest stages of high-mass star formation. We have mapped the whole IRDC with the Atacama Large Millimeter/submillimeter Array (ALMA) at 1.1 and 1.3 mm in dust continuum and line emission. The dust continuum reveals 22 cores distributed across the IRDC. In this work, we analyze the physical properties of the most massive core, ALMA1, which has no molecular outflows detected in the CO (2-1), SiO (5-4), and H$_2$CO (3-2) lines. This core is relatively massive ($M$ = 17.6 M$_\odot$), subvirialized (virial parameter $\alpha_{vir}=M_{vir}/M=0.14$), and is barely affected by turbulence (transonic Mach number of 1.2). Using the HCO$^+$ (3-2) line, we find the first detection of infall signatures in a relatively massive, prestellar core (ALMA1) with the potential to form a high-mass star. We estimate an infall speed of 1.54 km s$^{-1}$ and a high accretion rate of 1.96 $\times$ 10$^{-3}$ M$_\odot$ yr$^{-1}$. ALMA1 is rapidly collapsing, out of virial equilibrium, more consistent with competitive accretion scenarios rather than the turbulent core accretion model. On the other hand, ALMA1 has a mass $\sim$6 times larger than the clumps Jeans mass, being in an intermediate mass regime ($M_{J}=2.7<M\lesssim$ 30 M$_\odot$), contrary to what both the competitive accretion and turbulent core accretion theories predict.Comment: 13 Pages, 5 Figures, 3 Table

CHEMICAL EVOLUTION IN HIGH-MASS STAR-FORMING REGIONS: RESULTS FROM THE MALT90 SURVEY

The chemical changes of high-mass star-forming regions provide a potential method for classifying their evolutionary stages and, ultimately, ages. In this study, we search for correlations between molecular abundances and the evolutionary stages of dense molecular clumps associated with high-mass star formation. We use the molecular line maps from Year 1 of the Millimetre Astronomy Legacy Team 90 GHz (MALT90) Survey. The survey mapped several hundred individual star-forming clumps chosen from the ATLASGAL survey to span the complete range of evolution, from prestellar to protostellar to H II regions. The evolutionary stage of each clump is classified using the Spitzer GLIMPSE/MIPSGAL mid-IR surveys. Where possible, we determine the dust temperatures and H2 column densities for each clump from Herschel Hi-GAL continuum data. From MALT90 data, we measure the integrated intensities of the N2H+, HCO+, HCN and HNC (1-0) lines, and derive the column densities and abundances of N2H+ and HCO+. The Herschel dust temperatures increase as a function of the IR-based Spitzer evolutionary classification scheme, with the youngest clumps being the coldest, which gives confidence that this classification method provides a reliable way to assign evolutionary stages to clumps. Both N2H+ and HCO+ abundances increase as a function of evolutionary stage, whereas the N2H+ (1-0) to HCO+ (1-0) integrated intensity ratios show no discernable trend. The HCN (1-0) to HNC(1-0) integrated intensity ratios show marginal evidence of an increase as the clumps evolve

Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA

Intratumoral heterogeneity contributes to cancer drug resistance, but the underlying mechanisms are not understood. Single-cell analyses of patient-derived models and clinical samples from glioblastoma patients treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) demonstrate that tumor cells reversibly up-regulate or suppress mutant EGFR expression, conferring distinct cellular phenotypes to reach an optimal equilibrium for growth. Resistance to EGFR TKIs is shown to occur by elimination of mutant EGFR from extrachromosomal DNA. After drug withdrawal, reemergence of clonal EGFR mutations on extrachromosomal DNA follows. These results indicate a highly specific, dynamic, and adaptive route by which cancers can evade therapies that target oncogenes maintained on extrachromosomal DNA

Risperidone Treatment of Autistic Disorder: Longer-Term Benefits and Blinded Discontinuation After 6 Months

Objective: Risperidone is effective for short-term treatment of aggression, temper outbursts, and self-injurious behavior in children with autism. Because these behaviors may be chronic, there is a need to establish the efficacy and safety of longer-term treatment with this agent. Method: The authors conducted a multisite, two-part study of risperidone in children ages 5 to 17 years with autism accompanied by severe tantrums, aggression, and/or self-injurious behavior who showed a positive response in an earlier 8-week trial. Part I consisted of 4-month open-label treatment with risperidone, starting at the established optimal dose; part II was an 8-week randomized, double-blind, placebo-substitution study of risperidone withdrawal. Primary outcome measures were the Aberrant Behavior Checklist irritability subscale and the Clinical Global Impression improvement scale. Results: Part I included 63 children. The mean risperidone dose was 1.96 mg/day at entry and remained stable over 16 weeks of open treatment. The change on the Aberrant Behavior Checklist irritability subscale was small and clinically insignificant. Reasons for discontinuation of part I included loss of efficacy (N=5) and adverse effects (N=1). The subjects gained an average of 5.1 kg. Part II included 32 patients. The relapse rates were 62.5% for gradual placebo substitution and 12.5% for continued risperidone; this difference was statistically significant. Conclusions: Risperidone showed persistent efficacy and good tolerability for intermediate-length treatment of children with autism characterized by tantrums, aggression, and/or self-injurious behavior. Discontinuation after 6 months was associated with a rapid return of disruptive and aggressive behavior in most subjects